Hoxa-AS3: A Potential Drug Target and Biomarker (G100133311)

Target Name: HOXA-AS3

NCBI ID: G100133311

HOXA-AS3

Other Name(s): HOXA-AS3 variant 1 | HOXA cluster antisense RNA 3, transcript variant 1 | HOXA cluster antisense RNA 3 | HOXA6as

Hoxa-AS3: A Potential Drug Target and Biomarker

Hoxa-AS3, also known as Hoxa-117, is a protein that is expressed in human tissues and has been identified as a potential drug target and biomarker. The protein is a member of the Hoxa family, which is known for its role in cell signaling and is involved in the development and maintenance of tissues. Hoxa-AS3 has been shown to play a role in the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Drug Target Potential

One of the main reasons for the potential drug targeting of Hoxa-AS3 is its involvement in cell signaling pathways. Hoxa-AS3 has been shown to play a role in the regulation of cell growth, differentiation, and survival. It has been shown to promote the growth and survival of various cell types, including cancer cells. Therefore, Hoxa-AS3 may be a good candidate for a drug that targets cell signaling pathways and inhibits the growth and survival of cancer cells.

Another potential drug target for Hoxa-AS3 is its role in the development and progression of neurodegenerative diseases. Hoxa-AS3 has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Therefore, Hoxa-AS3 may be a good candidate for a drug that targets neurodegenerative diseases and inhibits the development and progression of these diseases.

Biomarker Potential

In addition to its potential drug targeting, Hoxa-AS3 may also be a useful biomarker for the diagnosis and monitoring of various diseases. For example, Hoxa-AS3 has been shown to be involved in the development and progression of cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, Hoxa-AS3 may be a biomarker for these diseases and can be used for the diagnosis and monitoring of these diseases.

Expression and localization of Hoxa-AS3

Hoxa-AS3 is a protein that is expressed in various human tissues, including brain, heart, liver, and pancreas. It has been shown to localize to the endoplasmic reticulum (ER) and to be involved in the regulation of protein synthesis and localization.

Hoxa-AS3 functions as a negative regulator of the translation of the protein Asparagine, which is involved in the regulation of cell signaling pathways. Hoxa-AS3 has been shown to interact with Asparagine and to inhibit its translation into the ER. This interaction between Hoxa-AS3 and Asparagine has important implications for the regulation of protein synthesis and localization.

Hoxa-AS3 functions as a negative regulator of the translation of the protein Glutamine, which is involved in the regulation of energy metabolism. Hoxa-AS3 has been shown to interact with Glutamine and to inhibit its translation into the ER. This interaction between Hoxa-AS3 and Glutamine has important implications for the regulation of energy metabolism.

Conclusion

In conclusion, Hoxa-AS3 is a protein that is involved in the regulation of cell signaling pathways and has been shown to play a role in the development and progression of various diseases, including cancer and neurodegenerative diseases. In addition, Hoxa-AS3 may also be a useful biomarker for the diagnosis and monitoring of these diseases. Therefore, Hoxa-AS3 may be a potential drug target and biomarker for the treatment of various diseases.

Protein Name: HOXA Cluster Antisense RNA 3

The "HOXA-AS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXA-AS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets